AQW051

· Novartis

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for AQW051, covering 2007-06-22 to 2020-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia [Phase 2]